DKSH with clear analyst support, healthcare exposure underpins stock story

Analysts in Malaysia highlight DKSH’s resilient healthcare and consumer distribution model, while Swiss-listed DKSH Holding AG trades steadily on SIX with a solid earnings profile.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 15:19.

DKSH Holding AG (CH0012684657) remains on the radar of investors on the SIX Swiss Exchange as the group’s Asian operations draw renewed attention from research houses. In Malaysia, Hong Leong Investment Bank Research reiterates a positive stance on the related DKSH Holdings Malaysia on the back of rising healthcare expenditure.

What Hong Leong highlights

Hong Leong Investment Bank (HLIB) Research describes DKSH Holdings Malaysia as a resilient and defensive play thanks to its distribution of inelastic products in both consumer staples and healthcare segments. The Star summarizes the HLIB report HLIB maintains a “buy” rating on DKSH Holdings Malaysia and recently lifted its target price to 7.33 Malaysian ringgit per share.

According to the Malaysian coverage, DKSH is positioned to benefit from new healthcare partnerships, rising healthcare expenditure and increasing supply chain outsourcing in the region. The same report stresses the structural drivers for earnings The brokerage emphasizes the combination of premium and affordable products in the portfolio as a support for stable demand.

Consensus view on DKSH Holding AG

For the Swiss-listed DKSH Holding AG, MarketScreener data show an average analyst target price around 74.31 Swiss francs, compared with a last close near 61.90 francs. MarketScreener compiles the DKSH consensus This implies a double-digit percentage gap between current trading levels and the average target in the compiled sample.

The same consensus snapshot suggests a predominantly positive rating structure, with several houses on “buy” or equivalent recommendations for DKSH Holding AG. The consensus page lists target prices and recommendations Analysts cite the group’s asset-light distribution model and exposure to fast-growing Asian consumer and healthcare markets as core arguments.

How DKSH generates its revenue

DKSH generates most of its revenue by providing market expansion services in Asia for consumer goods and healthcare companies, including logistics, sales and marketing support. The group outlines its four business units in its investor materials In healthcare, DKSH distributes pharmaceuticals, medical devices and over-the-counter products for multinational and local manufacturers.

Where the shares trade today

DKSH Holding AG shares (CH0012684657) trade on the SIX Swiss Exchange; recent data show a last close of 61.90 Swiss francs, with an implied market capitalization in the mid-single-digit billion franc range based on exchange figures.

Key data on the DKSH Holding AG shares

• Company: DKSH Holding AG
• ISIN: CH0012684657
• WKN: 873799
• Ticker: DKSH
• Trading venue: SIX Swiss Exchange
• Price (as of 2026-06-24, 17:30): 61.90 CHF
• Market cap: around 4 billion CHF (as of 2026-06-24)
• Sector / industry: Industrials / Business Support Services
• Index membership: SPI
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer or solicitation to buy or sell any financial instrument. Investors should conduct their own research and consider their individual financial situation before making investment decisions.